corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 602

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Pritchard MS.
Conflicts of interest: conceptual and normative issues.
Acad Med 1996 Dec; 71:(12):1305-13


Abstract:

Growing university-industry ties, particularly in biomedical areas, naturally raise concerns about conflicts of interest. Such conflicts are essentially problems in business and professional ethics. As of the fall of 1995, all institutions seeking funding from either the Public Health Service or the National Science Foundation have been required to maintain and enforce a written policy on conflicts of interest. The PHS and the NSF also require the disclosure of “significant” financial interests that might affect the research. Although the PHS and NSF requirements may prove helpful, they are not sufficient for monitoring the full range of serious conflicts of interest that can arise in university-industry relations. The PHS and the NSF are basically concerned with potential bias in the design, conduct, and reporting of research. Their disclosure requirements are restricted to financial considerations of $10,000 or more. However, bias in research can result from conflicts of interest when much less is at stake financially. Furthermore, it can arise at both individual and institutional levels. This article attempts to provide a conceptual and normative analysis of conflicts of interest that better enables us to understand the subtleties that can be involved. This article is one of three in this issue of Academic Medicine that deal with issues of conflict of interest in university-industry research relationships. These articles are discussed in an overview that precedes them.

Keywords:
*analysis United States conflict of interest relationship between researchers, academic institutions and industry drug company sponsored research Public Health Service National Science Foundation disclosure ETHICAL ISSUES IN PROMOTION: LINKS BETWEEN HEALTH PROFESSIONALS AND INDUSTRY SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909